Management of thymomas

Critical Reviews in Oncology/Hematology

Volumn 65, Issue 2, 2008, Pages 109-120

  Wright, Cameron D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Radiation therapy; Surgery; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; OCTREOTIDE; PREDNISONE; VINCRISTINE;

CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HISTOLOGY; HUMAN; LOBECTOMY; METASTASIS; MYASTHENIA GRAVIS; PARANEOPLASTIC SYNDROME; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIODIAGNOSIS; RARE DISEASE; REVIEW; STERNOTOMY; THORACOTOMY; THYMOMA; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASM STAGING; PARANEOPLASTIC SYNDROMES; PROGNOSIS; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS;

EID: 37549069938     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.04.005     Document Type: Review

References (63)

1. Engels E.A., and Pfeiffer R.M. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105 (2003) 546-551
2. Morgenthaler T.I., Brown L.R., Colby T.V., et al. Thymoma Mayo Clin Proc 68 (1993) 1110-1123
3. Suadjian J.V., Enriquez P., Siverstein M.N., et al. The spectrum of diseases associated with thymoma: coincidence or syndrome?. Arch Intern Med 154 (1974) 374-379
4. Voltz R.D., Albrich W.E., Nagele A., et al. Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 49 (1997) 1454-1457
5. Gautel M., Lakey A., Barlow D.P., et al. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 43 (1993) 1581-1585
6. Bulkley G.B., Bass K.N., Stephenson R., et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 226 (1997) 324-335
7. Cumming W.J.K., and Hudgeson P. The role of plasmapheresis in preparing patients with myasthenia for thymectomy. Muscle Nerve 9 (1986) S155-S158
8. Tomiyama N., Muller N.L., Ellis S.J., et al. Invasive and noninvasive thymoma: distinctive CT features. J Comput Assist Tomogr 25 (2001) 388-393
9. Kubota K., Yamada S., Kondo T., et al. PET imaging of primary mediastinal tumours. Br J Cancer 73 (1996) 882-886
10. Kesler K.A., Rieger K.M., Ganjoo K.N., et al. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg 118 (1999) 692-701
11. Wright C.D., and Wain J.C. Acute presentation of thymoma with infarction or hemorrhage. Ann Thorac Surg 82 (2006) 1901-1904
12. Morrissey B., Adams H., Gibbs A.R., et al. Percutaneous needle biopsy of the mediastinum: review of 94 procedures. Thorax 48 (1993) 632-637
13. Rosai J., and Levine GD. Tumors of the thymus. In: Furminger H.I. (Ed). Atlas of tumor pathology. Fascile 13, Series 2 (1976), Armed Forces Institute of Pathology, Washington, DC
14. Bernatz P., Harrison E., and Clagett O. Thymoma. A clinicopathological study. J Thorac Cardiovasc Surg 42 (1961) 424-444
15. Levine G.D., and Rosai J. Thymic hyperplasia and neoplasia. A review of current concepts. Hum Pathol 9 (1978) 495-503
16. Marino M., and Muller-Hermelink H. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus. Virchows Arch Pathol Anat Histopathol 407 (1985) 119-149
17. Rosai J. Histological typing of tumors of the thymus. In: Sobin L.H. (Ed). WHO international classification of tumors (1999), Springer-Verlag, Berlin and Heidelberg, Germany
18. Muller-Hermelink H., Engel P., Harris N., et al. Tumors of the thymus. In: Travis W., Brambilla E., and Muller-Hermelink H. (Eds). Tumors of the lung, thymus and heart. Pathology and genetics (2004), IARC Press, Lyon
19. Okumura M., Ohta M., Tateyama H., et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94 (2002) 624-632
20. Masaoka A., Mondem Y., Nakahara K., et al. Follow-up study of thymoma with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
21. Masaoka A., Yamakawa Y., Niwa H., et al. Thymectomy and malignancy. Eur J Cardiothoracic Surg 8 (1994) 251-253
22. Schneider P.M., Fellbaum C., Fink U., et al. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol 4 (1996) 46-56
23. Nakagawa K., Asamura H., Matsuno Y., et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126 (2003) 1134-1140
24. Port J.L., and Ginsberg R.J. Surgery for thymoma. Chest Surg Clin North Am 11 (2001) 421-437
25. Kaiser L.R., and Thymoma. The use of minimally invasive resection techniques. Chest Surg Clin North Am 4 (1994) 185-194
26. Roviaro G., Rebuffat C., Varonli F., et al. Videothoracoscopic excision of mediastinal masses: indications and techniques. Ann Thorac Surg 58 (1994) 1679-1684
27. Landreneau R.J., Dowling R.D., Castillo W.M., et al. Thoracoscopic resection of an anterior mediastinal tumor. Ann Thorac Surg 54 (1992) 142-144
28. Acuff T.E., Mack M.J., Ryan W.H., et al. Thoracoscopic thymoma resection [comment]. Ann Thorac Surg 55 2 (1993) 562-563
29. Curran W.J., Kornstein F.J., Brooks J.J., et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6 (1988) 1722-1727
30. Pollack A., Komaki R., Cox J.D., et al. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys 23 (1992) 1037-1043
31. Ogawa K., Uno T., Toita T., et al. Postoperative radiotherapy for patients with completely resected thymoma. Cancer 94 (2002) 1405-1413
32. Haniuda M., Morimoto M., Nishimura H., et al. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 54 (1992) 311-315
33. Mangi A.A., Wright C.D., Allan J.S., et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 74 (2002) 1033-1037
34. Singhal S., Shrager J.B., Rosenthal D.I., et al. Comparison of stages: thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76 (2003) 1635-1642
35. Kondo K., and Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 (2003) 878-885
36. Rena O., Papalia E., Oliaro A., et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?. Eur J Cardiothorac Surg 31 (2007) 109-113
37. Mangi A.A., Wain J.C., Donahue D.M., et al. Adjuvant radiation of stage III thymoma: is it necessary?. Ann Thorac Surg 79 (2005) 1834-1839
38. Macchiarini P., Chella A., Ducci F., et al. Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma. Cancer 68 (1991) 706-713
39. Berruti A., Borasio P., Gerbino A., et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 81 (1999) 841-845
40. Rea F., Sartori F., Loy M., et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106 (1993) 543-549
41. Shin Dm, Walsh G.L., Komake R., et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129 (1998) p. 100
42. Kim E.S., Putnam J.B., Komaki R., et al. Phase II study of a multidisciplinary approach with induction chemotherapy followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44 (2004) 369-379
43. Venuta F., Rendina E.A., Longo F., et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 (2003) 1866-1872
44. Lucchi M., Ambrogi M.C., Duranti L., et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg 79 (2005) 1840-1844
45. Yagi K., Hirata T., Fukuse T., Yokomise H., et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 61 (1996) 521-524
46. Akaogi E., Ohara K., Mitsui K., Onizuka M., et al. Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol 63 (1996) 17-22
47. Wright C.D. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 82 (2006) 1234-1239
48. Kohman L.J. Controversies in the management of malignant thymoma. Chest 112 (1997) 296S-300S
49. Loehrer P.J., Chen M., Kim K., et al. Cisplatin, doxorubicin and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15 (1997) 3093-3099
50. Loehrer P.J., Kim K.M., Aisner S.C., et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an Intergroup trial. J Clin Oncol 12 (1994) 1164-1168
51. Eng T.Y., and Thomas C.R. Radiation therapy in the management of thymic tumors. Sem Thorac Tardiovasc Surg 17 (2005) 32-40
52. Evans T.L., and Lynch T.J. Role of chemotherapy in the management of advanced thymic tumors. Sem Thorac cardiovasc Surg 17 (2005) 41-50
53. Kirkove C., Berghams J., Noel H., et al. Dramatic response of recurrent invasive thymoma to high doses of corticosteroids. J Clin Oncol 4 (1992) 64-66
54. Loeher P.J., Wang W., Johnson D.H., et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: a ECOG phase II trial. J Clin Oncol 22 (2004) 293-299
55. Giaccone G. Treatment of malignant thymoma. Curr Opin Oncol 17 (2005) 140-146
56. Ciccone A.M., and Rendina E.A. Treatment of recurrent thymic tumors. Sem Thorac Cardiovasc Surg 17 (2005) 27-31
57. Regnard J.F., Zinzindohoue F., Magdeleinat P., et al. Results of re-resection for recurrent thymomas. Ann Thorac Surg 64 (1997) 1593-1598
58. Ruffini E., Mancuso M., Oliaro A., et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment and outcome. J Thorac Cardiovasc Surg 113 (1997) 55-63
59. Kirschner P.A. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 49 (1990) 550-555
60. Regnard J.F., Magdeleinat P., Dromer C., et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112 (1996) 376-384
61. Wright C.D., Wain J.C., Wong D.R., et al. Predictors of recurrence in thymic tumors: importance of invasion. WHO histology and size. J Thorac Cardiovasc Surg 130 (2005) 1413-1421
62. Wilkins K.B., Sheikh E., Green R., et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 230 (1999) 562-572
63. Welsh J.S., Wilkins K.B., Green R., et al. Association between thymoma and second neoplasms. JAMA 283 (2000) 1142-1143